c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Compugen (CGEN) Completes Enrollment in MAIA-Ovarian Trial, Eyes Phase III Data in 2027
GuruFocus | Nov 9, 2026 10:59 AM EST
Related Stocks: CGEN ,
Read original article